NDC product
Tucks Triple Relief Hemorrhoidal
NDC 10157-2126 · Blistex Inc.
Key facts
| Product NDC | 10157-2126 |
|---|---|
| Proprietary name | Tucks Triple Relief Hemorrhoidal |
| Nonproprietary name | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, and PHENYLEPHRINE HYDROCHLORIDE |
| Substances | WHITE PETROLATUM, GLYCERIN, PRAMOXINE HYDROCHLORIDE, PHENYLEPHRINE HYDROCHLORIDE |
| Dosage form | CREAM |
| Route | TOPICAL |
| Labeler | Blistex Inc. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M015 |
| Pharmacologic classes | Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE] and 2 more |
| Marketing start | Jan 6, 2025 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: